Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.60 |
| ▸ | PAM | P19021 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 4/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | PRKCA | P17252 | 3/20 | 0.50 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.50 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.50 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.50 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2703795 | 1.00 | DGKA (0.60) | DGKAPAMLMNAKDM4EDUSP3 | |
| SCHEMBL4622373 | 1.00 | DGKA (0.60) | DGKAPAMLMNAKDM4EDUSP3 | |
| SCHEMBL4422801 | 1.00 | DGKA (0.60) | DGKAPAMLMNAKDM4EDUSP3 | |
| SCHEMBL2700370 | 1.00 | DGKA (0.60) | DGKAPAMLMNAKDM4EDUSP3 | |
| SCHEMBL8731558 | 1.00 | DGKA (0.60) | DGKAPAMLMNAKDM4EDUSP3 | |
| SCHEMBL2704205 | 1.00 | DGKA (0.60) | DGKAPAMLMNAKDM4EDUSP3 | |
| SCHEMBL16308644 | 1.00 | DGKA (0.60) | DGKAPAMLMNAKDM4EDUSP3 | |
| SCHEMBL2534799 | 1.00 | DGKA (0.60) | DGKAPAMLMNAKDM4EDUSP3 | |
| SCHEMBL9479896 | 1.00 | DGKA (0.60) | DGKAPAMLMNAKDM4EDUSP3 | |
| SCHEMBL30268601 | 1.00 | DGKA (0.60) | DGKAPAMLMNAKDM4EDUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118496584-A | Modified cycloolefin copolymer and preparation method and application thereof | 拓烯科技(衢州)有限公司 | 2024-08-16 | — | — | CN | claimed |
| CN-118496584-B | Modified cycloolefin copolymer and preparation method and application thereof | 拓烯科技(衢州)有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-118496584-A | Modified cycloolefin copolymer and preparation method and application thereof | 拓烯科技(衢州)有限公司 | 2024-08-16 | — | — | CN | disclosed |
| CN-117987116-A | Oil-soluble viscosity reducer composition, and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-05-07 | — | — | CN | disclosed |
| US-8425941-B2 | Powder cosmetic composition | SHISEIDO COMPANY, LTD. (JP) | 2013-04-23 | — | — | US | disclosed |
| US-20100239680-A1 | Powder Cosmetic Composition | SHISEIDO COMPANY, LTD. (JP) | 2010-09-23 | — | — | US | disclosed |
| EP-2044924-A1 | POWDERY COSMETIC | Shiseido Company, Limited (JP) | 2009-04-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100239680-A1 | Powder Cosmetic Composition | CUTA, ITGB7, PIEZO1 | DGKA 3955/4885PAM 1876/4885LMNA 2039/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.